Navigation Links
Cobalis Corp. Launches National Television Commercials for PreHistin® Allergy Defense Formula
Date:5/10/2011

IRVINE, Calif., May 10, 2011 /PRNewswire/ -- Cobalis Corp. (CLSC.PK) announced today they have started airing 60-second television commercials for PreHistin® Allergy Defense Formula, on major national cable and satellite networks across the US.

The commercials, featuring leading US allergist Dr. Paul H. Ratner, MD, explain how PreHistin works at the root cause of allergies, giving seasonal and year-round sufferers the first truly new advance in allergies in many years -- a safe and effective, side-effect free, all natural product intended, in the words of Dr. Ratner, to "help restore a normal response to seasonal and year-round allergies, which is no allergic response at all!"

The commercials were created to help build the PreHistin brand to consumers and allergy sufferers, and drive traffic to the pharmacy retailers across the US who now carry PreHistin in their allergy section. The commercials are now being placed on national cable networks and satellite cable providers, in a planned $5 million TV advertising campaign reaching a daily audience of over 300 million Americans, such as ION, Reelz, Great American Country, Style, Cooking Channel, ABC Family, BBC, BIO, OWN, E!, Lifetime, Oxygen, Soapnet, Womens' Entertainment, Style and many others.

The spots not only present the PreHistin story and explain the real cause of allergies, but prompt viewers that PreHistin is available now at fine pharmacies everywhere, and to "ask your pharmacist for PreHistin today."

Marty Marion, Cobalis CEO said, "We are excited to announce the start of our national TV campaign for PreHistin, which was selected as "Best New Product of 2011" out of a field of over a thousand products at the recent ECRM Cough, Cold and Allergy show. We are committed to supporting those retailers and pharmacies who are selling PreHistin, and television is just one of the support channels we are engaging to drive traffic, stimulate brand awareness and increase sales."

Cobalis President Chas Radovich said, "We believe that when allergy sufferers learn the PreHistin story they will try PreHistin for its ability to naturally restore a normal non-reactive response to allergens with no side effects or sedation. We thank the retailers who have brought PreHistin into their stores, and who are partnering with us to build PreHistin into a national brand."

PreHistin is now on shelves at one of the nation's two largest drugstore chains, as well as many fine regional and local pharmacies, and is expected to be on the shelf at most pharmacy and grocery shelves across the country very quickly.

ABOUT PREHISTIN® ALLERGY DEFENSE FORMULA

PreHistin® Allergy Defense Formula is a patented cobalamin complex that helps rebalance the immune system to lower allergen antibody IgE levels, and regulate the release of symptom-linked histamine. PreHistin is a cherry-flavored lozenge dissolved under the tongue and then swallowed twice a day, usually starting before the allergy season, or taken daily for those suffering from year-round allergies. PreHistin has no known side effects, is 100% non-drowsy, and has no contraindications with any other medications. In clinical trials on thousands of allergy sufferers, PreHistin was shown to be safe and effective in reducing nasal symptoms.

ABOUT COBALIS CORP. -- PREHISTIN®

Cobalis Corp. is a specialty pharmaceutical, nutraceutical and preventive healthcare product development and marketing company. Its flagship product, PreHistin® Allergy Defense Formula, "The World's First Pre-Histamine", is designed to mitigate overproduction of IgE levels and restore a normal response to seasonal and year-round indoor and outdoor allergens. PreHistin is now available without prescription for both long-term and daily use.

For PreHistin product information please visit http://www.PreHistin.com or call toll free 1-877-4POLLEN (1-877-476-5536). For additional company information please visit the corporate website at http://www.Cobalis.com

CONTACT

Cobalis Corp.
16795 Von Karman, Suite 200
Irvine, CA 92606
949-260-0123 (pacific time)

Chas Radovich, President
Martin Marion, CEO
info@cobalis.com


'/>"/>
SOURCE Cobalis Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cobalis Corp. Receives $415,000 First Purchase Order from Major Retail Pharmacy for PreHistin® Allergy Defense Formula
2. Cobalis Corp. Announces Second Update Conference Call for Investors on October 5, 2010
3. Cobalis Corp. Provides Marketing Update Conference Call for Investors
4. BAETA Corp. Expands Market Awareness Programs
5. ThermoGenesis Corp. to Announce Third Quarter Fiscal 2011 Results On May 5, 2011
6. Immune Design Corp. Appoints Pharma and Biotech Executive Carlos V. Paya, MD, PhD as Chief Executive Officer
7. Oxford Finance Corporation Provides a $2 Million Equipment Facility to Synta Pharmaceuticals Corp.
8. BioSpecifics Technologies Corp. Announces Launch of XIAPEX® by Pfizer for Treatment of Dupuytrens Contracture in Europe
9. Cantel Medical Corp. to Present at the Needham & Company 10th Annual Healthcare Conference
10. NephRx Corp. Awarded U.S. Patent for Use of Novel Growth Factor Peptide NX002 in Inflammatory Bowel Disease
11. NephRx Corp. Awarded New U.S. Patent for Oral Mucositis Agent NX002
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, 2016 ... Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, the ... announced today online at www.diabetesscholars.org by the ... diabetes stand in the way of academic and community ... Foundation,s scholarship program since 2012, and continues to advocate ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
Breaking Medicine News(10 mins):